custom ad
NewsJanuary 23, 2002

y LISA SINGHANIA AP Business WriterNEW YORK (AP) -- Technology buyers set off a modest rally on Wall Street Wednesday, encouraged by lower stock prices from the market's recent selloff and some mildly positive outlooks in the beleaguered sector. The gains were tentative and selective, however, coming late in a session mostly characterized by fluctuations. ...

y LISA SINGHANIA

AP Business WriterNEW YORK (AP) -- Technology buyers set off a modest rally on Wall Street Wednesday, encouraged by lower stock prices from the market's recent selloff and some mildly positive outlooks in the beleaguered sector.

The gains were tentative and selective, however, coming late in a session mostly characterized by fluctuations. The indecisiveness reflected what has become a trend -- although stocks occasionally manage small advances, the market has been unable to sustain any broad, upward move because of worries about the timing and strength of an economic recovery.

Analysts say investors are waiting to hear more corporations say that business is improving. So far, most haven't.

The Dow Jones industrial average closed up 17.16, or 0.2 percent, at 9,730.96, according to preliminary calculations.

The strongest gains came in the technology-focused Nasdaq composite index, which rose 39.85, or 2.1 percent, to 1,922.38.

The Standard & Poor's 500 index advanced 8.87, or 0.8 percent, at 1,128.18.

"What you're seeing today is a little bit of money being put back to work as the market tries to grind away through earnings season," said Charles White, portfolio manager at Avatar Associates. "Although we've come back to the reality that the recovery is probably not as immediate as people had thought, things don't seem to be getting worse, so they are buying."

Semiconductor equipment maker Novellus rose $3.42, or 9.4 percent, to $39.65 after beating Wall Street fourth-quarter estimates by a penny. A positive forecast for 2002 from European software maker SAP AG was also rewarded. The stock gained $2.49 to $36.80.

Investors also bid Pfizer up $1 to $41.80 after the pharmaceutical company met Wall Street's expectations for the fourth quarter.

Trading reflected Wall Street's skittishness about making sizable commitments -- and worries that corporate performance might not justify high stock prices.

IBM and General Electric fell after The Wall Street Journal published stories discussing their accounting practices. IBM lost $2.60 to $107.90, while GE fell 65 cents to $37.65. The recent collapse of Enron, and the subsequent scandal about its bookkeeping, has made many investors unsure of how much credence to give earnings reports.

Receive Daily Headlines FREESign up today!

Wall Street's hesitance might also have been related to new budget projections, showing the U.S. government will spend more than it takes in this year and in 2003. The nonpartisan Congressional Budget Office says the shortfall was caused by the recession, the $1.35 trillion, 10-year tax cut approved last year and the cost of the war on terrorism.

Wednesday's trading marked a brief respite from the downturn stocks have taken in recent weeks. After rebounding rapidly from the lows that followed the Sept. 11 attacks, the market is now at levels last seen in December. The Dow is now down 2.9 percent for the year, while the Nasdaq has lost 1.4 percent and the S&P has dropped 1.7 percent.

Stock prices have dropped this month as Wall Street studies fourth-quarter results and tries to predict when business and stock prices will improve. So far, earnings have been generally satisfacatory and in many cases have met previously lowered estimates. But investors been disheartened by the lack of bullish predictions for business performance going ahead.

Some of the tech sector's bellwethers, including Intel and IBM, have instead indicated they don't know if a turnaround is occurring. Intel was up 73 cents Wednesday at $32.43, while IBM fell $2.48 to $108.02.

Investors are also cautious after losing money in 2000 and 2001. Many don't want to buy until they're sure business won't deteriorate further. They worry that some of the market's spectacular rebound from its post-terror attack lows might be based on unfounded optimism about a recovery. Even improving economic news has failed to improve their mood.

"The market is really in a digestive phase more than anything else. It's had such a sharp move off the bottom and there's skepticism about where we go from here," said Marc Klee, portfolio manager for the John Hancock Technology Fund. "You've got a tug of war going on here and it's probably going to continue for a while."

Advancing issues led decliners nearly 2 to 1 on the New York Stock Exchange. Volume came to 1.43 billion shares, compared with 1.31 billion Tuesday.

The Russell 2000 index rose 8.02 to 477.45.

Overseas, Japan's Nikkei stock average fell 0.1 percent. In Europe, Germany's DAX index gained 2.3 percent, Britain's FT-SE 100 was up 0.6 percent, and France's CAC-40 advanced 0.1 percent.

------

On the Net:

New York Stock Exchange: http://www.nyse.com

Nasdaq Stock Market: http://www.nasdaq.com

Story Tags
Advertisement

Connect with the Southeast Missourian Newsroom:

For corrections to this story or other insights for the editor, click here. To submit a letter to the editor, click here. To learn about the Southeast Missourian’s AI Policy, click here.

Advertisement
Receive Daily Headlines FREESign up today!